HC Wainwright Boosts Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $60.00

Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) had its price target boosted by HC Wainwright from $25.00 to $60.00 in a report published on Monday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Longboard Pharmaceuticals’ Q4 2023 earnings at ($0.52) EPS, FY2023 earnings at ($2.28) EPS, […]

Related Keywords

California ,United States ,American , ,Analyst Recommendations For Longboard Pharmaceuticals ,Hedge Funds Weigh In On Longboard Pharmaceuticals ,News Ratings For Longboard Pharmaceuticals Daily ,American International Group Inc ,Longboard Pharmaceuticals Inc ,Longboard Pharmaceuticals ,Bourgeon Capital Management ,Wells Fargo Company ,Cantor Fitzgerald ,Longboard Pharmaceuticals Stock Down ,Citigroup Inc ,Free Report ,Pharmaceuticals Stock Down ,Get Free Report ,State Teachers Retirement System ,Capital Management ,American International Group ,Longboard Pharmaceuticals Daily ,Nasdaq Lbph ,Lbph ,Medical ,Boost Price Target ,Hc Wainwright ,